H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Biogen, Inc. | 35 | $110,219 | $77,600 - $126,610 | 97.1% |
| Genentech, Inc. | 2 | $141,388 | $116,376 - $166,400 | 100.0% |
| Satellite Biosciences, Inc. | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| ULTRAGENYX PHARMACEUTICAL, INC. | 1 | $128,752 | $128,752 - $128,752 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| II | 21 | $110,219 | $84,448 - $128,752 |
| I | 16 | $108,659 | $77,600 - $122,325 |
| Unspecified | 1 | $116,376 | $116,376 - $116,376 |
| Principal | 1 | $166,400 | $166,400 - $166,400 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Cambridge | MA | 31 | $110,219 |
| Research Triangle Park | NC | 2 | $83,988 |
| Newton | MA | 1 | $120,000 |
| CAMBRIDGE | MA | 1 | $105,872 |
| RESEARCH TRIANGLE PARK | NC | 1 | $110,427 |
| San Diego | CA | 1 | $116,376 |
| South San Francisco | CA | 1 | $128,752 |
These roles are variations of Scientist II, Technical Development with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| SCIENTIST I, TECHNICAL DEVELOPMENT | 43 | $100,526 | |
| Scientist II, Technical Development | 26 | $112,056 | |
| Scientist, Technical Development | Unspecified | 1 | $116,376 |
| Principal Scientist, Technical Development | 1 | $166,400 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 7 | $96,075 | 85.7% |
| 2022 | 10 | $110,219 | 100.0% |
| 2023 | 4 | $108,410 | 100.0% |
| 2024 | 9 | $109,100 | 100.0% |
| 2025 | 6 | $118,163 | 100.0% |
| 2026 | 3 | $120,000 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Biogen, Inc. | 35 | $110,219 | 97.1% |
| Genentech, Inc. | 2 | $141,388 | 100.0% |
| Satellite Biosciences, Inc. | 1 | $120,000 | 100.0% |
| ULTRAGENYX PHARMACEUTICAL, INC. | 1 | $128,752 | 100.0% |